Rivaroxaban crushed tablet suspension characteristics and relative bioavailability in healthy adults when administered orally or via nasogastric tube
Author:
Affiliation:
1. Global Clinical PharmacologyJanssen Research and Development, LLCTitusvilleNJUSA
2. Janssen Research and DevelopmentLLCRaritanNJUSA
3. Janssen Scientific AffairsLLCRaritanNJUSA
Funder
Janssen Scientific Affairs, LLC
Publisher
Wiley
Subject
Pharmacology (medical),Pharmaceutical Science
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpdd.123
Reference19 articles.
1. Pharmacodynamic and pharmacokinetic basics of rivaroxaban
2. In vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939-an oral, direct Factor Xa inhibitor
3. The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor
4. Oral direct factor Xa inhibitors for stroke prevention in atrial fibrillation
5. Safety, pharmacodynamics, and pharmacokinetics of single doses of BAY 59-7939, an oral, direct factor Xa inhibitor
Cited by 46 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Venetoclax Clinical Pharmacokinetics After Administration of Crushed, Ground or Whole Tablets;Clinical Therapeutics;2024-05
2. Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease;Nature Reviews Cardiology;2024-03-20
3. An extension of biorelevant fed-state dissolution tests to clinical pharmacokinetics – A study on gastrointestinal factors influencing rivaroxaban exposure and efficacy in atrial fibrillation patients;International Journal of Pharmaceutics;2024-01
4. Pharmacokinetics and pharmacodynamics of direct oral anticoagulants;Expert Opinion on Drug Metabolism & Toxicology;2023-11-24
5. Peripheral Arterial Disease and the Pharmacist’s Role in Management;Journal of Clinical Pharmacy and Therapeutics;2023-08-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3